Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)

NCT00901849 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Low-grade Gliomas

Interventions

DRUG: Tarceva and Rapamycin

Sponsor

Roger Packer

Collaborators

[object Object]